Startup profile · funding coverage
Safe Superintelligence funding, valuation and investors
AI lab focused on building safe superintelligence — founded by Ilya Sutskever.
Keep track of Safe Superintelligence
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Growth
~$2B · April 2025
Latest known valuation
$32B
Growth · April 2025
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Palo Alto, California
Investors in latest funding
Lead: Greenoaks
Other: Andreessen Horowitz , Sequoia Capital , Lightspeed Venture Partners
Overview
Safe Superintelligence Inc. (SSI) is an AI research lab founded by former OpenAI chief scientist Ilya Sutskever and Daniel Levy, focused on building superintelligent systems with safety as the primary objective. The company raised approximately $1B in September 2024 at roughly $5B valuation, then ~$2B in April 2025 at $32B led by Greenoaks. Andreessen Horowitz, Sequoia Capital, and Lightspeed Venture Partners participated alongside DST Global. SSI operates with minimal public product disclosure — research-first, no consumer chatbot launch.
Why Safe Superintelligence is interesting
SSI is one of the few independent frontier-lab bets with top-tier VC sponsorship — capital still flows to foundation models even as application layers explode.
Product & use cases
SSI is a research lab pursuing safe superintelligence — no public API or consumer product as of mid-2026. The company emphasizes safety-first frontier model development over rapid commercialization.
- Frontier AI research with safety constraints
- Potential future enterprise and government model licensing (not yet public)
- Long-horizon AGI capability development
Key facts
- Apr 2025: ~$2B at $32B valuation led by Greenoaks — Calcalist/CB Insights
- Sep 2024: ~$1B at ~$5B led by a16z, Sequoia, DST — Reuters
- Founded by Ilya Sutskever (ex-OpenAI chief scientist) and Daniel Levy
- No public consumer product; research-first lab
- a16z, Sequoia, Lightspeed in VCT directory
Funding history (newest first)
Growth
2025-04 ~$2B Valuation: $32B- Greenoaks (lead)
- Andreessen Horowitz (participant)
- Sequoia Capital (participant)
- Lightspeed Venture Partners (participant)
Source: https://www.calcalistech.com/ctechnews/article/hkjv0y0r11e
Investors in our directory
Funds linked from Safe Superintelligence's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Sutskever's technical reputation and ability to raise billions without shipping a product — signals investor belief in team over near-term revenue.
SSI is a bet that safety-first frontier research can attract capital without consumer distribution. $32B valuation (Apr 2025) prices extreme optionality with minimal public product. Competes with OpenAI, Anthropic, and DeepMind for researchers and compute.
-
OpenAI direct
Sutskever co-founded OpenAI; SSI competes for frontier talent and capital.
-
Anthropic direct
Safety-focused frontier lab with Claude product line.
-
Google DeepMind incumbent
Massive research budget and Gemini models; corporate not startup structure.
-
xAI direct
Musk-backed frontier lab with Grok; different safety positioning.
Notable stories
- Sutskever left OpenAI in 2024 after the board crisis and launched SSI with an explicit mission to pursue superintelligence safely — one of the largest seed rounds in history at ~$1B.
- SSI's April 2025 round at $32B valuation came with no public product launch, reflecting pure talent-and-mission premium.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Safe Superintelligence's financing or category context.
FAQs about Safe Superintelligence
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.